<unk> , sold under the brand name Zokinvy, is a medication used to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies in people one year of age and older. The most common side effects included nausea vomiting, headache ,diarrhea, infection, decreased appetite and fatigue.<unk>  was approved for medical use in the United States in November 2020. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
Lonafarnib
Tepotinib
Icotinib
Afatinib
Dabrafenib
Nilotinib
Lestaurtinib
Crizotinib